SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
President Donld Trump petitioned the Supreme Court to reinstate an FDA rule mandating a doctor's office visit for patients to obtain mifepristone, which is used to terminate an early pregnancy. (Photo: Robin Marty/Flickr)
Amid Pandemic, Trump Petitions Supreme Court to Make Potential Covid-19 Exposure 'the Price of Abortion Care'
"We've already blocked this policy in two federal courts—and we plan to do so again," said the ACLU.
Aug 26, 2020
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.